FAQ
Got questions? We’ve got answers.
We have implemented specific protocol to deal with COVID-19 according to health authorities. Please click here for more information: COVID-19 MESSAGE
Experion welcomes investor discussions. Learn more about our company at our investor page here: INVESTOR PAGE or download our investor deck here: INVESTOR PRESENTATION
TSXV:EXP OTCQB:EXPFF FRANKFURT:MB31
We are licensed to sell flower to provincial distribution across Canada and national sales of extractions are coming soon. Our Medical License allows us to sell flower directly to qualified patients.
Experion Products are avaialable under our Citizen Stash brand in BC, AB, SK, MN, YT and NT.
Our cultivation capacity between our internal cultivation and external grow partners will produce 2,500 KG per year of biomass. Our processing capabilities of flower and pre-rolls has the capability of processing over 4,000 KG’s per year.
We are planning to launch Experion value-added products later in FY2020 starting with edibles and then extracts and concentrates in the Q1 2021.
The oversupply being speculated in the industry is from large producers who are unable to compete in the premium, craft cannabis market. There is no oversupply of premium, craft cannabis which is the only kind grown by Experion.
Experion is focused on serving its current patient base. We are not accepting new patients at this time. Please subscribe to our email list to be notified when we are accepting new patients: SUBSCRIBE
LET’S CONFIRM YOU’RE AT LEGAL AGE TO ENTER OUR SITE.
You must be of legal age in accordance with the law of your province to access this website and/or to purchase cannabis. By entering this site you agree to our terms and conditions and privacy policy.